Literature DB >> 25176174

A comment on Fond and colleagues' systematic review and meta-analysis of ketamine in the treatment of depressive disorders (Psychopharmacology 2014; Jul 20 [Epub ahead of print]).

Alexander McGirr1, Marcelo T Berlim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25176174     DOI： 10.1007/s00213-014-3731-y

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  10 in total

1.  A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression.

Authors:  Nancy Diazgranados; Lobna Ibrahim; Nancy E Brutsche; Andrew Newberg; Phillip Kronstein; Sami Khalife; William A Kammerer; Zenaide Quezado; David A Luckenbaugh; Giacomo Salvadore; Rodrigo Machado-Vieira; Husseini K Manji; Carlos A Zarate
Journal:  Arch Gen Psychiatry       Date:  2010-08

2.  The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS.

Authors:  Gerald W Valentine; Graeme F Mason; Rosane Gomez; Madonna Fasula; June Watzl; Brian Pittman; John H Krystal; Gerard Sanacora
Journal:  Psychiatry Res       Date:  2011-01-12       Impact factor: 3.222

3.  Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial.

Authors:  Carlos A Zarate; Nancy E Brutsche; Lobna Ibrahim; Jose Franco-Chaves; Nancy Diazgranados; Anibal Cravchik; Jessica Selter; Craig A Marquardt; Victoria Liberty; David A Luckenbaugh
Journal:  Biol Psychiatry       Date:  2012-01-31       Impact factor: 13.382

Review 4.  Glutamatergic modulators: the future of treating mood disorders?

Authors:  Carlos Zarate; Rodrigo Machado-Vieira; Ioline Henter; Lobna Ibrahim; Nancy Diazgranados; Giacomo Salvadore
Journal:  Harv Rev Psychiatry       Date:  2010 Sep-Oct       Impact factor: 3.732

Review 5.  Ketamine administration in depressive disorders: a systematic review and meta-analysis.

Authors:  Guillaume Fond; Anderson Loundou; Corentin Rabu; Alexandra Macgregor; Christophe Lançon; Marie Brittner; Jean-Arthur Micoulaud-Franchi; Raphaelle Richieri; Philippe Courtet; Mocrane Abbar; Matthieu Roger; Marion Leboyer; Laurent Boyer
Journal:  Psychopharmacology (Berl)       Date:  2014-07-20       Impact factor: 4.530

Review 6.  Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders.

Authors:  Gerard Sanacora; Carlos A Zarate; John H Krystal; Husseini K Manji
Journal:  Nat Rev Drug Discov       Date:  2008-05       Impact factor: 84.694

Review 7.  A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes.

Authors:  A McGirr; M T Berlim; D J Bond; M P Fleck; L N Yatham; R W Lam
Journal:  Psychol Med       Date:  2014-07-10       Impact factor: 7.723

8.  Small-dose ketamine improves the postoperative state of depressed patients.

Authors:  Akira Kudoh; Yoko Takahira; Hiroshi Katagai; Tomoko Takazawa
Journal:  Anesth Analg       Date:  2002-07       Impact factor: 5.108

9.  A randomized controlled trial of intranasal ketamine in major depressive disorder.

Authors:  Kyle A B Lapidus; Cara F Levitch; Andrew M Perez; Jess W Brallier; Michael K Parides; Laili Soleimani; Adriana Feder; Dan V Iosifescu; Dennis S Charney; James W Murrough
Journal:  Biol Psychiatry       Date:  2014-04-03       Impact factor: 13.382

10.  Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder.

Authors:  Mehdi Ghasemi; Mohammad H Kazemi; Abolghasem Yoosefi; Abbas Ghasemi; Pedram Paragomi; Homayoun Amini; Mohammad H Afzali
Journal:  Psychiatry Res       Date:  2013-12-13       Impact factor: 3.222
  10 in total
  2 in total

1.  Sevoflurane Exerts an Anti-depressive Action by Blocking the HMGB1/TLR4 Pathway in Unpredictable Chronic Mild Stress Rats.

Authors:  Zhenggang Guo; Feng Zhao; Ye Wang; Ye Wang; Miaomiao Geng; Yilei Zhang; Qingxia Ma; Xiuzheng Xu
Journal:  J Mol Neurosci       Date:  2019-07-31       Impact factor: 3.444

2.  Ketamine's effectiveness in unipolar versus bipolar depression.

Authors:  Guillaume Fond; Laurent Boyer
Journal:  Psychopharmacology (Berl)       Date:  2014-10-15       Impact factor: 4.530
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.